Quarterly report pursuant to Section 13 or 15(d)

ASSET PURCHASE AGREEMENT WITH HEALION (Details Narrative)

v3.23.2
ASSET PURCHASE AGREEMENT WITH HEALION (Details Narrative) - Healion Pharmaceuticals Inc [Member] - Asset Purchase Agreement [Member]
$ in Millions
Feb. 02, 2023
USD ($)
Asset Acquisition [Line Items]  
Consideration paid $ 1.2
Research and development costs $ 1.2